Unsorted
BioLLM’s Exploration of AI’s Unexpected Evolution
Over the past several years, Artificial Intelligence (AI) and Large Language Models (LLMs) have become increasingly integrated into modern…
Tag
Biotech
Business
Novartis strikes deal with UK biotech for up to US$1.7 billion
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Novartis will pay UK biotech…
Business
Novartis agrees to buy Avidity in US$12 billion biotech deal
Novartis agreed to buy biotechnology company Avidity Biosciences in a deal that values it at US$12 billion, according to the Swiss…
News
Who Is Serhat Gumrukcu? California Biotech Tycoon Found Guilty in Murder-for-Hire Plot of Dad of Six Over Failed Oil Deal
A biotech tycoon from California has been found guilty of masterminding a murder-for-hire plot targeting his former business partner — a…
Business
Hong Kong stock ETFs get record China money on AI, biotech craze
Mainland retail traders are being lured by the outperformance of the city’s equities Hot themes from artificial intelligence (AI) to…
Business
Novartis to buy US biotech Tourmaline Bio for US$1.4 billion
Novartis agreed to buy Tourmaline Bio in a deal valued at about US$1.4 billion as the Swiss drugmaker continues to pursue bolt-on deals to…
Business
Biotech company Amgen set to build $600-million research center in Thousand Oaks
Biotech company Amgen is investing $600 million into a new research center for its Thousand Oaks campus. The new site will create hundreds…
Business
A*Star biotech spin-off Mirxes trims losses to US$28.4 million as top line grows
Higher revenue is driven by increased contributions from its early detection and precision multi-omics segment Local biotech startup…
Business
Biotech Beauty Company Debut Raises $20 Million
Biotech beauty company Debut has secured $20 million in investment to enhance its AI-driven ingredient discovery platform and expand its…
Business
Australian biotech giant CSL to spin off vaccine unit Seqirus, cut 15% of workforce
While the Melbourne-based company employs around 32,000 people, no firm number was put on the job cuts Australian biotech giant CSL said…
Business
China’s biotech moment ignites a 60% stock rally that beats AI
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds are tipping…
Business
Merck held talks to buy biotech MoonLake for over US$3 billion: FT
K has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times reported on Monday,…
Business
LVMH-backed Biotech Firm Sparxell Secures 1.9M Euros in Funding
LONDON— Sparxell, a Cambridge-based plant-based colorant start-up, has secured 1.9 million euros in funding from the European Innovation…
Business
Singapore-based biotech firm Nuevocor raises US$45 million in Series B round
Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new and…
News
LA Biotech Investor Convicted in Murder-for-Hire Plot of Vermont Partner Who Threatened to Report Him to Authorities Over Fraud
A federal jury has convicted the accused mastermind behind a murder-for-hire plot of all charges brought against him in the 2018 killing…
Business
Initial MAS review group incentives could pull in regional biotech, fintech players: observers
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too MARKET watchers…
Business
MAS review group incentives could pull in regional biotech, fintech players: observers
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too MARKET watchers…
Business
GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion…
Business
Johnson & Johnson is in talks to buy US$10 billion biotech Intra-Cellular
JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments for central…